Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-EN
Language English English
Date Updated 2019-06-25 2019-06-19
Drug Identification Number 00870420 00870420
Brand name METRONIDAZOLE 5MG/ML INJECTION METRONIDAZOLE 5MG/ML INJECTION
Common or Proper name METRONIDAZOLE 500MG IN 100ML SWI (SINGLE PACKS) 40EA/CA METRONIDAZOLE 500MG IN 100ML SWI (SINGLE PACKS) 40EA/CA
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients METRONIDAZOLE METRONIDAZOLE
Strength(s) 5MG 5MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100 mL 100 mL
ATC code J01XD J01XD
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-06-18 2019-06-18
Actual start date 2019-06-18 2019-06-18
Estimated end date 2019-07-02 2019-06-25
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Alternative available: JB3415 - METRONIDAZOLE 500MG IN 100ML SWI (QUAD (4) PACKS) 96EA/CA (24 packs of four). For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. Alternative available: JB3415 - METRONIDAZOLE 500MG IN 100ML SWI (QUAD (4) PACKS) 96EA/CA (24 packs of four). For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative.
Health Canada comments